Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Medicament for preventing and treating ischemic cerebrovascular diseases

A technology for ischemic and cerebrovascular diseases, applied in drug combinations, cardiovascular system diseases, pharmaceutical formulations, etc., can solve the problems of high mortality, high treatment costs, long disease duration, etc., to reduce mortality and inhibit venous thrombosis. and cerebral thrombosis

Active Publication Date: 2011-05-11
苏建峰
View PDF0 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Cerebrovascular disease is currently one of the three major diseases that threaten the health of the elderly and cause disability and high fatality rate. It has brought a heavy economic burden to the family. Due to the low cure rate of the disease, the patient has a disability left over, cannot take care of himself, suffers from physical discomfort and mental torture, and loses the ability to take care of himself due to illness and disability. The medical insurance has to pay a large amount every year. Large medical expenses have also brought a heavy burden to society and the government

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Medicament for preventing and treating ischemic cerebrovascular diseases
  • Medicament for preventing and treating ischemic cerebrovascular diseases
  • Medicament for preventing and treating ischemic cerebrovascular diseases

Examples

Experimental program
Comparison scheme
Effect test

Embodiment

[0099] Embodiment: The composition of Su Naotong pill is (weight unit: Kg) Gastrodia elata 10, Uncaria 10, Angelica 10, Salvia miltiorrhiza 10, Jixuenteng 10, Sanleng 10, Curcuma 10, Cassia chinensis 30, Ochre 30, Cornus 10, medlar 10, hawthorn 20, earthworm 10, achyranthes bidentata 10, jujube seed 10, vine 12, calamus 12;

[0100] Shichangpu: remove impurities, wash, moisten thoroughly, cut into thick slices, dry in the sun, and set aside;

[0101] Curcuma: remove impurities, soak for a while, wash, steam to soften, cut into thin slices, and dry; take Curcuma slices, add vinegar, mix well, moisten slightly, after the vinegar is exhausted, stir-fry over low heat until slightly yellow, and burnt spots can be seen. Take out and let cool, set aside. For every 10Kg of curcuma, use 2Kg of vinegar;

[0102] Triangular: Remove impurities, soak and moisten thoroughly, cut into thin slices, and dry to form triangular slices; take triangular slices, add vinegar and mix well, slightly...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a medicament for preventing and treating ischemic cerebrovascular diseases, in particular relates to a medicament for preventing and treating ischemic cerebrovascular diseases, which is prepared by using animal and plant Chinese herbal medicines, ores and shellfishes as raw materials. The medicament is prepared from gastrodia tuber, uncaria, angelica, red sage root, spatholobus stem, rhizoma sparganii, rhizoma zedoariae, concha haliotidis, ruddle, comus officinalis, medlar, hawthorn, earthworm, radix cyathulae, seed of wild jujube, caulis polygoni multiflori and rhizoma acori graminei. The medicament provided by the invention is mainly used in intervention of disease causes and risk factors of ischemic cerebrovascular diseases, has obvious effects on regulating and controlling blood pressure, reducing blood viscosity, reducing blood fat and resisting atherosclerosis, greatly lowers the morbidity rate and recurrence rate of cerebrovascular diseases, obviously improves the cure rate, improves the quality of life, and reduces the death rate.

Description

technical field [0001] The present invention relates to a pharmaceutical composition for preventing and treating ischemic cerebrovascular disease, which we call "Sunaotong Pills", in particular to a medicine composition for preventing and treating ischemia made from animals and plants, Chinese herbal medicine, ore and shellfish. Drugs for cerebrovascular disease. Background technique [0002] Cerebrovascular disease is a common and frequently-occurring disease of the nervous system. It is one of the three major diseases that cause human death at present. It is characterized by high incidence, high disability rate, high mortality rate, high recurrence rate, and 50% of survivors. ~70% of patients have severe disabilities, which brings heavy burden to society and family. The results of epidemiological surveys in my country from 1986 to 1990 showed that the incidence of stroke was 109.7-217 / 100,000, the prevalence was 719-745.6 / 100,000, and the mortality rate was 116-141.8 / 100,...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K36/9066A61P9/10A61K33/26A61K35/56A61K35/62
Inventor 苏建峰
Owner 苏建峰
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com